Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margarida Mesquita

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Medica Portuguesa|November 7, 2013
Hospital admissions for herpes zoster in Portugal between 2000 and 2010Margarida Mesquita, Filipe Froes
Cureus|August 13, 2024
The Importance of Early Diagnosis and Treatment in Septic Arthritis of the Temporomandibular Joint: A Case ReportJoão Oliveira, Margarida Mesquita, Sofia Correia, et al.
Pulmonary Therapy|May 7, 2020
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan<sup>®</sup> Retard) Compared with Other Formulations in Healthy VolunteersCeline Ollier, Ulrike Sent, Margarida Mesquita, et al.
The European Respiratory Journal|August 11, 2012
Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009Filipe Froes, António Diniz, Margarida Mesquita, et al.
International Journal of Surgery Case Reports|October 25, 2019
Bronchogenic cyst of the neck in an elder patient: A case reportInês Santos, João Barros, Teresa Lopes, et al.
Multidisciplinary Respiratory Medicine|April 10, 2020
An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to childrenAhmad Kantar, Ludger Klimek, Dorotheea Cazan, et al.
Head & Neck|September 9, 2015
Parotid metastasis of an amelanotic melanoma of the scalp: The great masqueraderTiago Neto, Richard Nunes, Isabel Amado, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 6, 2016
WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short reportIlda Patrícia Ribeiro, Francisco Caramelo, Francisco Marques, et al.
Vaccine: X|July 23, 2024
A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany)Frank Kowalzik, Daniel Teschner, Margarida Mesquita, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Medica Portuguesa|November 7, 2013
Hospital admissions for herpes zoster in Portugal between 2000 and 2010Margarida Mesquita, Filipe Froes
Cureus|August 13, 2024
The Importance of Early Diagnosis and Treatment in Septic Arthritis of the Temporomandibular Joint: A Case ReportJoão Oliveira, Margarida Mesquita, Sofia Correia, et al.
Pulmonary Therapy|May 7, 2020
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan<sup>®</sup> Retard) Compared with Other Formulations in Healthy VolunteersCeline Ollier, Ulrike Sent, Margarida Mesquita, et al.
The European Respiratory Journal|August 11, 2012
Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009Filipe Froes, António Diniz, Margarida Mesquita, et al.
International Journal of Surgery Case Reports|October 25, 2019
Bronchogenic cyst of the neck in an elder patient: A case reportInês Santos, João Barros, Teresa Lopes, et al.
Multidisciplinary Respiratory Medicine|April 10, 2020
An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to childrenAhmad Kantar, Ludger Klimek, Dorotheea Cazan, et al.
Head & Neck|September 9, 2015
Parotid metastasis of an amelanotic melanoma of the scalp: The great masqueraderTiago Neto, Richard Nunes, Isabel Amado, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 6, 2016
WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short reportIlda Patrícia Ribeiro, Francisco Caramelo, Francisco Marques, et al.
Vaccine: X|July 23, 2024
A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany)Frank Kowalzik, Daniel Teschner, Margarida Mesquita, et al.
Pageof 1